Santen EMEA raises almost €100,000 to support the ophthalmology community during COVID-19
As COVID-19 continues to impact hundreds of thousands of people across the world, many healthcare systems are struggling to cope with the strain imposed by the virus.
As a global healthcare company our mission is to contribute to the well-being of patients, their loved ones and consequently to society – and we take our role in supporting communities seriously. That’s why, for the past six weeks, staff from across the region have donated funds as part of the 10,000 Hours initiative to support ophthalmology organisations in maintaining care for patients in the face of impacted services, reduced staffing or limited resources.
Following many generous donations by Santen staff and with each donation matched Euro for Euro by Santen, a grand total of €98,913 has been raised to support numerous ophthalmology organisations across EMEA. The amount raised has been donated at a grass roots level to local ophthalmology charities or initiatives that continue to provide care and support to the ophthalmology community during the pandemic.
This €98,913 is equivalent to 1,717 working hours, meaning that in total, since 4 July 2018, Santen EMEA has now donated 3,340 hours of our collective time towards our 10,000 hours target.
As the COVID-19 pandemic continues, Santen would like to express our heartfelt gratitude to all those working to provide care at the frontline, as well as those who continue to support people with eye health conditions. All of our thoughts are with those directly affected by the virus, particularly those who are sick, and we remain grateful and inspired by healthcare workers and their continued efforts to care for patients and support our communities.
Document no: NP-No product-EMEA-0042
Date of preparation: June 2020
An update on Santen’s actions regarding COVID-19
As a healthcare company that is well represented across the globe. Santen’s mission is to contribute to the well-being of patients, their loved ones and consequently to society.
We take our role in limiting the risk to our people and those around us very seriously. We are continuously monitoring developments and taking appropriate actions to help protect and support the ophthalmology community.
Our manufacturing network remains fully operational and as the global situation evolves, we will continue to take the steps necessary to safeguard the reliable supply of our medicines. Mindful that our medicines are used to treat long-term conditions that impact on sight and quality of life, we have also been working to help patients receive their medicines despite potential movement and logistics restrictions.
We remain in constant dialogue with healthcare professionals and patient organisations across EMEA, to understand how best we can continue to support them. We are also adopting and embracing digital solutions to allow ongoing medical education and continued scientific exchange.
To reduce the risks of COVID-19 infections, we continue to minimise the working from our offices, our commercial teams are not currently operating in the field and international business travel is not permitted.
We will continue to protect and support the community we serve throughout this crisis.
Document no: NP-No product-EMEA-0037
Date of preparation: May 2020
